Literature DB >> 21357727

Breast cancer incidence rates in U.S. women are no longer declining.

Carol DeSantis1, Nadia Howlader, Kathleen A Cronin, Ahmedin Jemal.   

Abstract

BACKGROUND: Several publications reported breast cancer incidence rates continued to decrease among white women, following the decline of about 7% from 2002 to 2003. However, none of these reports exclusively examined the trend after 2003. In this paper, we examined breast cancer incidence rates among non-Hispanic (NH) white women from 2003 to 2007 to determine whether the decrease in breast cancer incidence rates indeed persisted through 2007. In addition, we present breast cancer incidence trends for NH black and Hispanic women and postmenopausal hormone use for all three racial/ethnic groups.
METHODS: Breast cancer incidence rates were calculated by race/ethnicity, age and ER status using data from the Surveillance, Epidemiology, and End Results (SEER) 12 registries for 2000 to 2007. Prevalence of postmenopausal hormone use was calculated using National Health Interview Survey data from 2000, 2005, and 2008.
RESULTS: From 2003 to 2007, overall breast cancer incidence rates did not change significantly among NH white women in any age group. However, rates increased (2.7% per year) for ER+ breast cancers in ages 40 to 49, and decreased for ER- breast cancers in ages 40 to 49 and 60 to 69. Similarly, overall breast cancer incidence rates did not change significantly for black and Hispanic women. Hormone use continued to decrease from 2005 to 2008 in all groups, although the decreases were smaller compared to those from 2000 to 2005.
CONCLUSIONS: The sharp decline in breast cancer incidence rates that occurred from 2002 to 2003 among NH white women did not continue through 2007. IMPACT: Further studies are needed to better understand the recent breast cancer trends. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21357727     DOI: 10.1158/1055-9965.EPI-11-0061

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  45 in total

1.  Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.

Authors:  A Mansour; M Nabil; R Ali-Labib; H Said; F Annos
Journal:  Med Oncol       Date:  2011-12-08       Impact factor: 3.064

Review 2.  A review of cancer in U.S. Hispanic populations.

Authors:  Robert W Haile; Esther M John; A Joan Levine; Victoria K Cortessis; Jennifer B Unger; Melissa Gonzales; Elad Ziv; Patricia Thompson; Donna Spruijt-Metz; Katherine L Tucker; Jonine L Bernstein; Thomas E Rohan; Gloria Y F Ho; Melissa L Bondy; Maria Elena Martinez; Linda Cook; Mariana C Stern; Marcia Cruz Correa; Jonelle Wright; Seth J Schwartz; Lourdes Baezconde-Garbanati; Victoria Blinder; Patricia Miranda; Richard Hayes; George Friedman-Jiménez; Kristine R Monroe; Christopher A Haiman; Brian E Henderson; Duncan C Thomas; Paolo Boffetta
Journal:  Cancer Prev Res (Phila)       Date:  2012-02

3.  Anti-Oligomannose Antibodies as Potential Serum Biomarkers of Aggressive Prostate Cancer.

Authors:  Denong Wang; Laila Dafik; Rosalie Nolley; Wei Huang; Russell D Wolfinger; Lai-Xi Wang; Donna M Peehl
Journal:  Drug Dev Res       Date:  2013-03       Impact factor: 4.360

Review 4.  Breast cancer in young women: an overview.

Authors:  Zoi Anastasiadi; Georgios D Lianos; Eleftheria Ignatiadou; Haralampos V Harissis; Michail Mitsis
Journal:  Updates Surg       Date:  2017-03-04

5.  Incidence of breast cancer in the United States: current and future trends.

Authors:  William F Anderson; Hormuzd A Katki; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2011-07-13       Impact factor: 13.506

6.  The past, present, and future of cancer incidence in the United States: 1975 through 2020.

Authors:  Hannah K Weir; Trevor D Thompson; Ashwini Soman; Bjørn Møller; Steven Leadbetter
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

7.  Neighborhood Predictors of Mammography Barriers Among US-Based Latinas.

Authors:  Yamile Molina; Jesse J Plascak; Donald L Patrick; Sonia Bishop; Gloria D Coronado; Shirley A A Beresford
Journal:  J Racial Ethn Health Disparities       Date:  2016-04-08

8.  Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.

Authors:  Philip S Rosenberg; Kimberly A Barker; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

9.  Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.

Authors:  Nadia Howlader; Anne-Michelle Noone; Mandi Yu; Kathleen A Cronin
Journal:  Am J Epidemiol       Date:  2012-07-25       Impact factor: 4.897

10.  Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.

Authors:  William F Anderson; Philip S Rosenberg; Lucia Petito; Hormuzd A Katki; Bent Ejlertsen; Marianne Ewertz; Birgitte B Rasmussen; Maj-Britt Jensen; Niels Kroman
Journal:  Int J Cancer       Date:  2013-06-13       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.